The shoutbox is open for the CC

[slugworth008]

That was short, positive and to the point. It would appear that SNY bailed. And also that MNKD was glad they did - Specifically pointing out that pricing and marketing strategies can now be corrected.

[kc]

Ok call they have plans to partner and licence immediately and worldwide

[factspls88]

And I was worried about running out of battery on my iPad. Sheesh. Never a dull moment.

[nylefty]

I liked the fact that they realize that the price of Afrezza was too high...lowering it will get the insurance companies on board.

[bradleysbest]

Yep, lets hope they create some demand for the product.

[karma2]

Last century I remember trying hard get this girl to go out a date....and then we did...and after it was over [and now] ...feels the same.

[blakjak]

I agree. Why did SNY price this above the competition, and hence not get Tier 2 insurance coverage, makes me think we got royal f*kd

[wmdhunt]

I hope to look back on this day as the beginning of good things. As of now, I think it's time for stunned silence. I did buy some today. Gawd, Al and I are getting to be drinking buddies.

[pktrump]

My take

1. Mathew was pissed.
2. He emphatically stated not the end of AFZ and MNKD.
3. Clean slate. AN opportunity.
4. Approx 60 M in cash: last to mid 2016.
5. Exploring TS deals and other alliances in the US and with emphasis "AND INTERNATIONALLY".
6. Duane and Matthew will be at JPM con and will answer investor questions at that time.
7. The other phrase that stood out to me was near the end regarding the overwhelming support and positive feedback of patients and physicians and a need to correct the trajectory of AFZ sales. I took this
to mean MNKD was very unhappy with SNY's efforts and reluctance to change strategy in 2015.

[rch51]

Ok. Received notice yesterday from Sanofi.  Did not say how long they have known however. Sounded to me like they were aware pricing and other changes were needed quite some time ago. (Expect pricing to be a big issue going forward). MNKD is moving forward with Afrezza and nothing is off the table (my words, not Matt). Funding situation is stable with enough cash on hand to carry through mid-2016   and additional measures to be taken to further that time line (into 2017). Very firm on their commitment to Afrezza and the company is going to continue to do everything possible to keep the product out there for current and new users. TS is the cornerstone of the company - more details on TS deals that are in works as they are available (heard that before). Matt only speaker. New CEO not avail (hmm) today. Will not take questions.

Pretty short.  Not bad but I would like to have heard some Q&A.  I'm holding tight. 

[silentknight]

I'm no fan of Matt but I think he did pretty well there. They are scrambling to recover after they were notified yesterday.  I wouldn't expect him to lay out their plans for the next 10 years with one day to prepare.

My takeaways:

1) They aren't giving up.  That's important to me and to patients I'm sure. He made it clear they intended to correct mistakes (in a jab at Sanofi) and make it a success.  That's the first time I've heard Matt express any determination on a call in a LONG time.

2) They aren't shutting the doors tomorrow.  They have cash (not a lot, but enough) to keep things going for a few months until they make other arrangements.  Also keeping the milestone payments was also good to hear.

In all, I'm taking it as an attempt to calm the storm with assurances that they aren't packing it up and throwing in the towel.  I think that's what needed to be said. I expect we'll hear more next week.

CEO needs to get involved here though. That's crucial. 

[sluggobear]

So 60 million and 30 million loan. That won't go through 2016 at current burn rates will it? Going to be hard on the employees unless there is some funding miracle waiting in the wings. Sure wish we heard from DeSisto. So he wasn't prepared to have this happen on his first day of employment.

[linw0918]

Jan 5, 2016 16:53:26 GMT -5 wmdhunt said:

I hope to look back on this day as the beginning of good things. As of now, I think it's time for stunned silence. I did buy some today. Gawd, Al and I are getting to be drinking buddies.

I bought 500 shares today. Will be drinking with you. It seemed like they were caught off guard but they have 60 million cash plus ALs
30 million and they were upbeat. Gotta luv that

[trenddiver]

Jan 5, 2016 16:53:21 GMT -5 blakjak said:

I agree. Why did SNY price this above the competition, and hence not get Tier 2 insurance coverage, makes me think we got royal f*kd

World wide picture.  Foreign pricing is based on U.S.  So they wanted high price.

[Deleted]

Jan 5, 2016 16:55:45 GMT -5 silentknight said:

I'm no fan of Matt but I think he did pretty well there. They are scrambling to recover after they were notified yesterday.  I wouldn't expect him to lay out their plans for the next 10 years with one day to prepare.

My takeaways:

1) They aren't giving up.  That's important to me and to patients I'm sure. He made it clear they intended to correct mistakes (in a jab at Sanofi) and make it a success.  That's the first time I've heard Matt express any determination on a call in a LONG time.

2) They aren't shutting the doors tomorrow.  They have cash (not a lot, but enough) to keep things going for a few months until they make other arrangements.  Also keeping the milestone payments was also good to hear.

In all, I'm taking it as an attempt to calm the storm with assurances that they aren't packing it up and throwing in the towel.  I think that's what needed to be said. I expect we'll hear more next week.

CEO needs to get involved here though. That's crucial. 

CEO will get involved but on his first day, not a good idea.  Matt was good.  The less said, the better.  He let us know there is enough cash to run through Q3 so a bit of room to breath.